Evidence map›Paper›PMID 42477877›Full record

ArticleBioinformatics (Oxford, England)2026

A de novo algorithm for allele reconstruction from Oxford nanopore amplicon reads, with application to CYP2D6.

Scott D Brown, Lisa Dreolini, Agata Minor, Michelle Mozel, Nancy Wong, Sharon Mar, Amanda Lieu, Maimun Khan, Amanda Carlson, Monica Hrynchak and 2 more

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Scott D BrownDepartment of Basic and Translational Research, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.ORCID 0000-0003-4000-4148
Lisa DreoliniDepartment of Basic and Translational Research, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
Agata MinorDepartment of Pathology and Laboratory Medicine; Molecular Cytogenetics Laboratory, Royal Columbian Hospital, New Westminster, BC V3L 3W7, Canada.
Michelle MozelDepartment of Anesthesiology and Perioperative Medicine, Royal Columbian Hospital, New Westminster, BC V3L 0A2, Canada.
Nancy WongDepartment of Pathology and Laboratory Medicine; Molecular Cytogenetics Laboratory, Royal Columbian Hospital, New Westminster, BC V3L 3W7, Canada.
Sharon MarDepartment of Pathology and Laboratory Medicine; Molecular Cytogenetics Laboratory, Royal Columbian Hospital, New Westminster, BC V3L 3W7, Canada.ORCID 0009-0000-5777-1277
Amanda LieuDepartment of Pathology and Laboratory Medicine; Molecular Cytogenetics Laboratory, Royal Columbian Hospital, New Westminster, BC V3L 3W7, Canada.
Maimun KhanDepartment of Pathology and Laboratory Medicine; Molecular Cytogenetics Laboratory, Royal Columbian Hospital, New Westminster, BC V3L 3W7, Canada.
Amanda CarlsonDepartment of Pathology and Laboratory Medicine; Molecular Cytogenetics Laboratory, Royal Columbian Hospital, New Westminster, BC V3L 3W7, Canada.
Monica HrynchakDepartment of Pathology and Laboratory Medicine; Molecular Cytogenetics Laboratory, Royal Columbian Hospital, New Westminster, BC V3L 3W7, Canada.
Robert A HoltDepartment of Basic and Translational Research, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.ORCID 0000-0002-7259-1247
Perseus I MissirlisDepartment of Anesthesiology and Perioperative Medicine, Royal Columbian Hospital, New Westminster, BC V3L 0A2, Canada.

Funding

Royal Columbian Hospital Foundation
6 · The paper itself

Abstract

motivationThe Oxford Nanopore Technologies' sequencing platform offers a path towards bedside genomics, producing long reads that can completely cover a gene of interest, and detect any known or novel variant the gene contains. However, the analysis of these long reads to identify actionable genotypes remains challenging and typically requires customization depending on the target gene.

resultsHere, we describe a generic algorithm to accurately reconstruct allele sequences derived from long-reads of amplicon-based data. Rather than calling variants directly from these long-reads, our method takes a "sequence-first" approach, performing an unbiased reconstruction of the underlying amplicon sequences to generate high-confidence reconstructed allele sequences. This is done without user input of the target gene, allowing for any source amplicon to be reconstructed. These high-confidence reconstructed allele sequences are then compared to the genomic reference sequence of the gene to infer the specific diplotype present in the sample. This approach is agnostic towards the number of genes and alleles present and readily detects novel variants. We demonstrate our approach using three independent data sets for CYP2D6, a diverse and complex gene with over 175 known alleles of clinical significance. We show how our approach can accurately recover validated CYP2D6 diplotypes from 20 Coriell samples covering 14 distinct alleles, using different amplicons, flow cell versions, and depths. This includes inferring occurrences of allele duplication events from relative abundances of each allele, a critical factor for ascribing functional effects to a diplotype. Further, we demonstrate our approach's utility for other genomic regions, including HLA. AVAILABILITY: Custom code is available at the following GitHub repository, along with instructions for use and test data: https://github.com/scottdbrown/allele-reconstruction-long-read-amplicon-data. A snapshot of the code at the time of publication is available on Zenodo.org; doi 10.5281/zenodo.19716004. Raw .fastq sequence data for our three sequencing runs is available at the SRA under Bioproject PRJNA1357883 (https://www.ncbi.nlm.nih.gov/bioproject/1357883).

Indexed as

AlgorithmsAllelesCytochrome P-450 CYP2D6High-Throughput Nucleotide SequencingNanopore SequencingSequence Analysis, DNAGenomicsHumansCytochrome P-450 CYP2D6

Identifiers

PMID42477877
PMCPMC13437021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.